For citations:
Nedogoda S.V., Ledyaeva A.A., Chumachek E.V., Tsoma V.V., Salasyuk A.S., Lutova V.O., Popova E.A., Vlasov D.S., Bychkova O.I., Labaznikova V.A., Evdokimov K.S. Optimization of blood pressure control, organ protection and metabolic disorders using a fixed-dose combination of lisinopril+amlodipine+rosuvastatin in hypertensive patients after COVID-19. Russian Journal of Cardiology. 2021;26(12):4766. (In Russ.) https://doi.org/10.15829/1560-4071-2021-4766
Email this article 